Log In
Print
BCIQ
Print
Print this Print this
 

MSPrecise

  Manage Alerts
Collapse Summary General Information
Company DioGenix Inc.
DescriptionNext-generation sequencing assay that measures DNA mutations found in rearranged immunoglobin genes in B cells isolated from cerebrospinal fluid (CSF)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsDetermine risk of developing multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today